Literature DB >> 33229539

Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice.

Hao Hu1, Pavel N Zakharov1, Orion J Peterson1, Emil R Unanue2.   

Abstract

Autoimmune diabetes is one of the complications resulting from checkpoint blockade immunotherapy in cancer patients, yet the underlying mechanisms for such an adverse effect are not well understood. Leveraging the diabetes-susceptible nonobese diabetic (NOD) mouse model, we phenocopy the diabetes progression induced by programmed death 1 (PD-1)/PD-L1 blockade and identify a cascade of highly interdependent cellular interactions involving diabetogenic CD4 and CD8 T cells and macrophages. We demonstrate that exhausted CD8 T cells are the major cells that respond to PD-1 blockade producing high levels of IFN-γ. Most importantly, the activated T cells lead to the recruitment of monocyte-derived macrophages that become highly activated when responding to IFN-γ. These macrophages acquire cytocidal activity against β-cells via nitric oxide and induce autoimmune diabetes. Collectively, the data in this study reveal a critical role of macrophages in the PD-1 blockade-induced diabetogenesis, providing new insights for the understanding of checkpoint blockade immunotherapy in cancer and infectious diseases.

Entities:  

Keywords:  PD-1 blockade; autoimmune diabetes; exhausted CD8 T cells; monocyte-derived macrophages

Mesh:

Substances:

Year:  2020        PMID: 33229539      PMCID: PMC7733808          DOI: 10.1073/pnas.2019743117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  72 in total

1.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.

Authors:  Mahnaz Mellati; Keith D Eaton; Barbara M Brooks-Worrell; William A Hagopian; Renato Martins; Jerry P Palmer; Irl B Hirsch
Journal:  Diabetes Care       Date:  2015-06-26       Impact factor: 19.112

Review 3.  Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.

Authors:  Z Quandt; A Young; M Anderson
Journal:  Clin Exp Immunol       Date:  2020-02-28       Impact factor: 4.330

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

Review 5.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Authors:  Masao Hashimoto; Alice O Kamphorst; Se Jin Im; Haydn T Kissick; Rathi N Pillai; Suresh S Ramalingam; Koichi Araki; Rafi Ahmed
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

6.  The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  H S Jun; C S Yoon; L Zbytnuik; N van Rooijen; J W Yoon
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

7.  Massively parallel digital transcriptional profiling of single cells.

Authors:  Grace X Y Zheng; Jessica M Terry; Phillip Belgrader; Paul Ryvkin; Zachary W Bent; Ryan Wilson; Solongo B Ziraldo; Tobias D Wheeler; Geoff P McDermott; Junjie Zhu; Mark T Gregory; Joe Shuga; Luz Montesclaros; Jason G Underwood; Donald A Masquelier; Stefanie Y Nishimura; Michael Schnall-Levin; Paul W Wyatt; Christopher M Hindson; Rajiv Bharadwaj; Alexander Wong; Kevin D Ness; Lan W Beppu; H Joachim Deeg; Christopher McFarland; Keith R Loeb; William J Valente; Nolan G Ericson; Emily A Stevens; Jerald P Radich; Tarjei S Mikkelsen; Benjamin J Hindson; Jason H Bielas
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

8.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

9.  Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.

Authors:  Laura Strauss; Mohamed A A Mahmoud; Jessica D Weaver; Natalia M Tijaro-Ovalle; Anthos Christofides; Qi Wang; Rinku Pal; Min Yuan; John Asara; Nikolaos Patsoukis; Vassiliki A Boussiotis
Journal:  Sci Immunol       Date:  2020-01-03

10.  The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

Authors:  Mohammed Javeed I Ansari; Alan D Salama; Tanuja Chitnis; R Neal Smith; Hideo Yagita; Hisaya Akiba; Tomohide Yamazaki; Miyuki Azuma; Hideyuki Iwai; Samia J Khoury; Hugh Auchincloss; Mohamed H Sayegh
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  9 in total

1.  Self-Renewing Islet TCF1+ CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1- Terminal Effectors during the Progression of Type 1 Diabetes.

Authors:  Ashley E Ciecko; David M Schauder; Bardees Foda; Galina Petrova; Moujtaba Y Kasmani; Robert Burns; Chien-Wei Lin; William R Drobyski; Weiguo Cui; Yi-Guang Chen
Journal:  J Immunol       Date:  2021-09-10       Impact factor: 5.426

Review 2.  Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies.

Authors:  Daniel Ronen; Aseel Bsoul; Michal Lotem; Suzan Abedat; Merav Yarkoni; Offer Amir; Rabea Asleh
Journal:  Vaccines (Basel)       Date:  2022-03-31

Review 3.  Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.

Authors:  Golnaz Morad; Beth A Helmink; Padmanee Sharma; Jennifer A Wargo
Journal:  Cell       Date:  2021-10-07       Impact factor: 66.850

4.  Autoreactive CD8 T cells in NOD mice exhibit phenotypic heterogeneity but restricted TCR gene usage.

Authors:  Moujtaba Y Kasmani; Ashley E Ciecko; Ashley K Brown; Galina Petrova; Jack Gorski; Yi-Guang Chen; Weiguo Cui
Journal:  Life Sci Alliance       Date:  2022-06-06

Review 5.  Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism.

Authors:  Diane Mourad; Nadim S Azar; Assaad A Eid; Sami T Azar
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

6.  Chromogranin A Deficiency Confers Protection From Autoimmune Diabetes via Multiple Mechanisms.

Authors:  Neetu Srivastava; Hao Hu; Anthony N Vomund; Orion J Peterson; Rocky L Baker; Kathryn Haskins; Luc Teyton; Xiaoxiao Wan; Emil R Unanue
Journal:  Diabetes       Date:  2021-09-08       Impact factor: 9.461

7.  Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.

Authors:  Emi Kawada-Horitani; Shunbun Kita; Tomonori Okita; Yuto Nakamura; Hiroyuki Nishida; Yoichi Honma; Shiro Fukuda; Yuri Tsugawa-Shimizu; Junji Kozawa; Takaaki Sakaue; Yusuke Kawachi; Yuya Fujishima; Hitoshi Nishizawa; Miyuki Azuma; Norikazu Maeda; Iichiro Shimomura
Journal:  Diabetologia       Date:  2022-05-05       Impact factor: 10.460

Review 8.  Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer.

Authors:  Yanmeizhi Wu; Shan Yu; Hong Qiao
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

9.  Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor-induced diabetes.

Authors:  Ana Luisa Perdigoto; Songyan Deng; Katherine C Du; Manik Kuchroo; Daniel B Burkhardt; Alexander Tong; Gary Israel; Marie E Robert; Stuart P Weisberg; Nancy Kirkiles-Smith; Angeliki M Stamatouli; Harriet M Kluger; Zoe Quandt; Arabella Young; Mei-Ling Yang; Mark J Mamula; Jordan S Pober; Mark S Anderson; Smita Krishnaswamy; Kevan C Herold
Journal:  JCI Insight       Date:  2022-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.